Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Jefferson Research
$20.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Auxilium Pharmaceuticals Inc issues FY 2014 guidance; net income guidance below analysts' estimates


Friday, 28 Feb 2014 06:30am EST 

Auxilium Pharmaceuticals Inc:Expects FY 2014 global net revenues to be in the range of $450-$490 mln.FY 2014 net income on a non-GAAP basis to be in the range of $45-$50 mln.FY 2014 revenue of $489 mln and net income of $54 mln - Thomson Reuters I/B/E/S. 

Company Quote

34.7
0.675 +1.98%
19 Dec 2014